Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination of 18F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.

Korean journal of radiology - 1 Sept 2022

Li Shen, Li Yadi, Zhao Min, Wang Pengyuan, Xin Jun

Abstract excerpt

OBJECTIVE: To identify epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma based on 18F-fluorodeoxyglucose (FDG) PET/CT radiomics and clinical features and to distinguish EGFR exon 19 deletion (19 del) and exon 21 L858R missense (21 L858R) mutations using FDG PET/CT radiomics. MATERIALS AND METHODS: We retrospectively analyzed 179 patients with lung adenocarcinoma. They were randomly assigned...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Lung Neoplasms

Share to Mutation

Share to Positron Emission Tomography Computed Tomography

Source

Open in PubMed Open full text

Identifiers

PMID: 36047542
DOI: 10.3348/kjr.2022.0295
PMCID: PMC9434738

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination of 18F-Fluorodeoxyglucose PET/CT Radiomics and Clinical Features for Predicting Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.PMID 36047542Read ↗

18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinomaSemantic proximity Read ↗

3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinomaSemantic proximity Read ↗

Comparison of the radiomics-based predictive models using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinoma.Semantic proximity Read ↗

Comparison of the radiomics-based predictive models using machine learning and nomogram for epidermal growth factor receptor mutation status and subtypes in lung adenocarcinomaSemantic proximity Read ↗

The Predictive Value of 18F-FDG PET/CT Radiomics in EGFR Gene Mutation of Lung Adenocarcinoma.Semantic proximity Read ↗

Lung adenocarcinoma: development of nomograms based on PET/CT images for prediction of epidermal growth factor receptor mutation status and subtypes.Semantic proximity Read ↗

Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.Semantic proximity Read ↗

Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.Semantic proximity Read ↗

Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning.Semantic proximity Read ↗

Using CT image-based radiomics to predict EGFR mutations in lung adenocarcinomaSemantic proximity Read ↗

A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.Semantic proximity Read ↗

Prognostic and Predictive Value of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutant Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitors: A Single-Center Retrospective Study with Subgroup Analysis of 19del vs. L858RSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.